explore -WSS

explore

author：Wikipedia 2025-08-23 18:38:05 - browse：35279

Illustration of doctor with an computer text bubble for a face for a story on Chat GPT and AI – health tech coverage from STAT — Mike Reddy for STAT

Health care companies are racing to incorporate generative AI tools into their product pipelines and IT systems after the technology displayed an ability to perform many tasks faster, cheaper — and sometimes better — than humans.

But the rush to harness the power of so-called large language models, which are trained on vast troves of data, is outpacing efforts to assess their value. AI experts are still trying to understand, and explain, how and why they work better than prior systems, and what blind spots might undermine their usefulness in medicine.

It remains unclear, for example, how well these models will perform, and what privacy and ethical quandaries will arise, when they’re exposed to new types of data, such as genetic sequences, CT scans, and electronic health records. Even knowing exactly how much data must be fed into a model to achieve peak performance on a given task is still largely guesswork.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Free medical tuition alone isn't enough to close gaps in primary care

hotspot

WSS

HHS suspends federal funding for EcoHealth Alliance

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Oak Street deal isn't the answer to health care's woes

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Many immigrants are left out of maternal health programs

'Weather

leisure time

explore

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Obesity drug from Roche shows promise in early study

Walensky prepares to leave CDC — and Congress — behind

Many immigrants are left out of maternal health programs

Hepatitis C has a cure — but many Americans still lack access to it

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Dobbs anniversary: the lost opportunity of abortion as health care

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Trump demands the U.S. pay no more for drugs than other countries … again

Obesity drug from Roche shows promise in early study

focus

WuXi Biologics beefs up its lobbying operation

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

House GOP plan to stem drug shortages differs from Democrats’

focus

hotspot

explore

entertainment